SE7416251L - - Google Patents

Info

Publication number
SE7416251L
SE7416251L SE7416251A SE7416251A SE7416251L SE 7416251 L SE7416251 L SE 7416251L SE 7416251 A SE7416251 A SE 7416251A SE 7416251 A SE7416251 A SE 7416251A SE 7416251 L SE7416251 L SE 7416251L
Authority
SE
Sweden
Application number
SE7416251A
Other versions
SE423541B (sv
Inventor
M Hayashi
S Kori
H Wakatsuka
Y Konishi
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP14373873A external-priority patent/JPS5432774B2/ja
Priority claimed from JP372674A external-priority patent/JPS5418242B2/ja
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Publication of SE7416251L publication Critical patent/SE7416251L/xx
Publication of SE423541B publication Critical patent/SE423541B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7416251A 1973-12-25 1974-12-23 Forfarande for framstellning av trans-delta?722-prostaglandinforeningar SE423541B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14373873A JPS5432774B2 (xx) 1973-12-25 1973-12-25
JP372674A JPS5418242B2 (xx) 1973-12-29 1973-12-29

Publications (2)

Publication Number Publication Date
SE7416251L true SE7416251L (xx) 1975-06-26
SE423541B SE423541B (sv) 1982-05-10

Family

ID=26337362

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7416251A SE423541B (sv) 1973-12-25 1974-12-23 Forfarande for framstellning av trans-delta?722-prostaglandinforeningar

Country Status (11)

Country Link
US (1) US4024174A (xx)
AU (1) AU7678474A (xx)
CA (1) CA1066699A (xx)
CH (3) CH609043A5 (xx)
DE (1) DE2460285A1 (xx)
FI (1) FI373274A (xx)
FR (1) FR2255056B1 (xx)
GB (1) GB1483240A (xx)
LU (1) LU71563A1 (xx)
NL (1) NL189350C (xx)
SE (1) SE423541B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1525282A (en) * 1975-08-08 1978-09-20 Ono Pharmaceutical Co 16-chloroprostaglandin analogues
GB1588196A (en) * 1977-06-14 1981-04-15 Ono Pharmaceutical Co Prostaglandin analogues
DE2830079A1 (de) * 1978-07-08 1980-01-17 Hoechst Ag Neue prostaglandinderivate der delta 2,4-11-desoxy-pge-reihe
DE2834249A1 (de) * 1978-08-04 1980-02-28 Hoechst Ag Neue prostaglandinderivate in der delta 2-11-desoxy-pgf tief 2 bzw. pge tief 2 -reihe
JPS6033429B2 (ja) * 1980-04-28 1985-08-02 小野薬品工業株式会社 プロスタグランジン類似化合物
US4360688A (en) * 1981-05-21 1982-11-23 American Cyanamid Company Precursors and synthesis of d1-(methyl)-16,16-(dimethyl)-11-alpha, 15-alpha, beta-dihydroxy-9-oxo-2,13,-trans, trans-prostadienoates
US5166369A (en) * 1981-05-21 1992-11-24 American Cyanamid Company Precursors and synthesis of D1-(methyl)-16,16-(dimethyl)-11-alpha, 15-alpha, beta-dihydroxy-9-oxo-2,13,-trans, trans-prostadienoates
DE3347128A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 9-halogen-(delta)(pfeil hoch)2(pfeil hoch)-prostaglandinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
SE9403158D0 (sv) * 1994-09-21 1994-09-21 Pharmacia Ab New use of prostaglandins
US5616793A (en) * 1995-06-02 1997-04-01 Warner-Lambert Company Methods of making (S)-3-(aminomethyl)-5-methylhexanoic acid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE792803A (fr) * 1971-12-17 1973-03-30 Erba Carlo Spa Derives d'acide 8,12-diisoprostanoique optiquement actifs, leurpreparation et compositions en contenant
CH599147A5 (en) * 1973-07-09 1978-05-12 Sandoz Ag Long-acting synthetic prostaglandins

Also Published As

Publication number Publication date
NL189350C (nl) 1993-03-16
CH609043A5 (en) 1979-02-15
CH613444A5 (en) 1979-09-28
GB1483240A (en) 1977-08-17
FR2255056A1 (xx) 1975-07-18
CH613684A5 (en) 1979-10-15
AU7678474A (en) 1976-06-24
DE2460285A1 (de) 1975-07-03
US4024174A (en) 1977-05-17
NL7416804A (nl) 1975-06-27
CA1066699A (en) 1979-11-20
FI373274A (xx) 1975-06-26
NL189350B (nl) 1992-10-16
FR2255056B1 (xx) 1978-09-01
SE423541B (sv) 1982-05-10
LU71563A1 (xx) 1975-08-20

Similar Documents

Publication Publication Date Title
AU476761B2 (xx)
AU465372B2 (xx)
AU474593B2 (xx)
AU474511B2 (xx)
AU474838B2 (xx)
AU471343B2 (xx)
AU465453B2 (xx)
AU465434B2 (xx)
AU450229B2 (xx)
AU476714B2 (xx)
AU472848B2 (xx)
AU466283B2 (xx)
AU476696B2 (xx)
AU477823B2 (xx)
AU471461B2 (xx)
AU461342B2 (xx)
AR210729A1 (xx)
AU447540B2 (xx)
AU476873B1 (xx)
AU477824B2 (xx)
AU1891376A (xx)
BG19745A1 (xx)
BG20485A1 (xx)
AU479422A (xx)
AU479420A (xx)